在儿科肝移植中早期异构移植功能障碍的定义,预后和并发症分析:回顾性队列研究

相关实验视频

Updated: May 9, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Zhuyuan Si¹, Zhixin Zhang², Shengqiao Zhao²

¹Department of Organ Transplantation, Qilu Hospital of Shandong University, Jinan, China; Department of Liver Transplantation, Organ Transplantation Center, Tianjin First Central Hospital, Tianjin, China.

Journal of pediatric surgery

|February 11, 2025

概括

在儿科肝移植 (pLT) 中提出了早期异位移植功能障碍 (EAD) 的新定义. 这种精细的EAD定义改善了对儿科肝脏接受者的患者和移植存活率的预测,特别是那些接受已故捐赠者肝脏移植的人.

科学领域:

儿科移植儿科移植
肝病学肝病学是一种肝病学.
免疫学免疫学免疫学

背景情况:

早期异位移植功能障碍 (EAD) 的定义各不相同,并且对于儿科肝移植 (pLT) 没有很好的确立.
现有的成人EAD标准通常不适合儿童患者.

研究的目的:

开发和验证用于儿科肝移植的EAD的特定定义.
评估新的EAD定义在pLT中预测结果的改进适用性.

主要方法:

对1620名儿科肝移植患者 (<18岁) 的回顾性分析.
建议的EAD标准:INR≥2.8在第1天和AST>1500 IU/mL在7天内,或总 bilirubin≥5 mg/dL在第7天.
使用新定义与成人EAD定义对比90天的患者和移植存活率.

主要成果:

11.0%的pLT受益人符合新的EAD定义.
新的EAD定义显示,与成人定义相比,90天死亡率 (9.57) 和移植损失 (11.48) 的风险比率明显更高.
在已故供体肝移植 (DDLT) 接受者中,新的EAD定义产生了较高的死亡率 (10.98) 和移植损失 (11.24) 的风险比率.

结论:

成人EAD定义 (Olthoff的) 对于儿科肝移植是不够的.
新建立的EAD定义更适合儿科肝移植接受者,特别是那些接受DDLT的人.
这种精确的定义有助于在pLT中更好地分层风险和预测结果.

关键词:

早期的全移植功能障碍.移植损失移植损失移植损失儿科肝移植手术儿科肝移植手术幸存的生存方式

更多相关视频

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Published on: September 22, 2023

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

相关概念视频

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...